Early increase in the neuronal marker N-acetyl-aspartate with antidepressant treatment of major depression

Early increase in the neuronal marker N-acetyl-aspartate with antidepressant treatment of major depression

Detalhes bibliográficos
Main Authors:	Taylor, M, Godlewska, B, Norbury, R, Selvaraj, S, Near, J, Cowen, P
Formato:	Conference item
Publicado em:	2012

Registos relacionados

Early increase in marker of neuronal integrity with antidepressant treatment of major depression: 1H-magnetic resonance spectroscopy of N-acetyl-aspartate.
Por: Taylor, M, et al.
Publicado em: (2012)

Early changes in neural responses to emotional information predict clinical response to antidepressant treatment in depression
Por: Godlewska, B, et al.
Publicado em: (2014)

Neurochemistry of major depression: a study using magnetic resonance spectroscopy.
Por: Godlewska, B, et al.
Publicado em: (2015)

Early changes in emotional processing as a marker of clinical response to SSRI treatment in depression
Por: Godlewska, B, et al.
Publicado em: (2016)

Elevated cortical glutamate in young people at increased familial risk of depression.
Por: Taylor, M, et al.
Publicado em: (2011)

Depression resistant to tricyclic antidepressants.
Por: Cowen, P
Publicado em: (1988)

Depression resistant to tricyclic antidepressants.
Por: Cowen, P
Publicado em: (1988)

Serotonin, depression and antidepressant action
Por: Cowen, P
Publicado em: (2013)

Frontal glutamate and glutamine normalized after recovery front major depressive disorder: A proton magnetic resonance spectroscopy study
Por: Taylor, M, et al.
Publicado em: (2008)

Systematic review of pindolol augmentation of serotonergic antidepressant treatment for major depressive disorder
Por: Whale, R, et al.
Publicado em: (2005)

Short-term SSRI treatment normalises amygdala hyperactivity in depressed patients.
Por: Godlewska, B, et al.
Publicado em: (2012)

Increased neural response to fear in patients recovered from depression: a 3T functional magnetic resonance imaging study.
Por: Norbury, R, et al.
Publicado em: (2010)

Antidepressants in unipolar major depression: what we need to know
Por: Barber, S, et al.
Publicado em: (2016)

Short-term antidepressant treatment modulates amygdala response to happy faces.
Por: Norbury, R, et al.
Publicado em: (2009)

Biological markers in depression
Por: Cowen, P
Publicado em: (1989)

Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine.
Por: Pringle, A, et al.
Publicado em: (2012)

Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine
Por: Pringle, A, et al.
Publicado em: (2012)

Effects of escitalopram therapy on functional brain controllability in major depressive disorder
Por: Fang, F, et al.
Publicado em: (2022)

Antidepressants for bipolar depression.
Por: Ghaemi, SN, et al.
Publicado em: (2005)

Suicide, depression, and antidepressants.
Por: Cipriani, A, et al.
Publicado em: (2005)

Biological markers of depression.
Por: Cowen, P, et al.
Publicado em: (1991)

An investigation of EEG, genetic and cognitive markers of treatment response to antidepressant medication in patients with major depressive disorder: a pilot study.
Por: Spronk, D, et al.
Publicado em: (2011)

Associations between diffusion and perfusion parameters, N-acetyl aspartate, and lactate in acute ischemic stroke.
Por: Cvoro, V, et al.
Publicado em: (2009)

Cognitive neuropsychological theory of antidepressant action: A modern-day approach to depression and its treatment
Por: Godlewska, BR, et al.
Publicado em: (2020)

Efficacy markers in depression
Por: Harmer, C, et al.
Publicado em: (2011)

Efficacy markers in depression.
Por: Harmer, C, et al.
Publicado em: (2011)

Effects of ebselen addition on emotional processing and brain neurochemistry in depressed patients unresponsive to antidepressant medication
Por: Ramli, FF, et al.
Publicado em: (2024)

Review: Antidepressants increase clinical response and remission in bipolar depression without increasing induction of mania
Por: Gijsman, H, et al.
Publicado em: (2005)

Bipolar depression and treatment with antidepressants.
Por: Goodwin, G
Publicado em: (2012)

When less is more: a functional magnetic resonance imaging study of verbal working memory in remitted depressed patients.
Por: Norbury, R, et al.
Publicado em: (2014)

Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo
Por: Fu, CHY, et al.
Publicado em: (2024)

Back to the future: the neurobiology of major depression.
Por: Cowen, P
Publicado em: (1998)

Tyrosine depletion does not cause depressive relapse in antidepressant-treated patients.
Por: McTavish, S, et al.
Publicado em: (2004)

ON or OFF?: Modulating the N-methyl-D-aspartate receptor in major pepression.
Por: Chan, S, et al.
Publicado em: (2017)

Normal glutamate but elevated myo-inositol in anterior cingulate cortex in recovered depressed patients
Por: Taylor, M, et al.
Publicado em: (2009)

Normal glutamate but elevated myo-inositol in anterior cingulate cortex in recovered depressed patients.
Por: Taylor, M, et al.
Publicado em: (2009)

Nefazodone--a novel antidepressant--may increase REM sleep.
Por: Sharpley, A, et al.
Publicado em: (1992)

Changes in motor excitability in major depression: State or trait marker?
Por: Ebmeier, K, et al.
Publicado em: (2002)

Short-term SSRI treatment remediates amygdala hyperactivity in depressed patients
Por: Godlewska, B, et al.
Publicado em: (2011)

Antidepressants might work for people with major depression: where do we go from here?
Por: Cipriani, A, et al.
Publicado em: (2018)